Patents Assigned to BIOGENERA S.P.A.
  • Oligonucleotides for modulating gene expression and uses thereof
    Patent number: 10752900
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: August 25, 2020
    Assignee: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • OLIGONUCLEOTIDES FOR MODULATING GENE EXPRESSION AND USES THEREOF
    Publication number: 20180282731
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Application
    Filed: June 15, 2018
    Publication date: October 4, 2018
    Applicant: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • Oligonucleotides for modulating gene expression and uses thereof
    Patent number: 10023867
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoral or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: July 17, 2018
    Assignee: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro